Neutralizing Antibodies against SARS-CoV-2 Beta and Omicron Variants Inhibition Comparison after BNT162b2 mRNA Booster Doses with a New PETIA sVNT Assay.
Marta FogolariBruno Daniele LeoniMarina De CesarisRita ItalianoFlavio DaviniGinevra Azzurra MiccoliDaniele DonatiLuigi ClericoAndrea StanzialeGiovanni SaviniNicola PetrosilloMassimo CiccozziLorenzo SommellaElisabetta RivaPaolo FaziiSilvia AngelettiPublished in: Diagnostics (Basel, Switzerland) (2023)
This study correlates vaccine-induced IgG expression and neutralizing activity using a new PETIA assay, suggesting its usefulness for SARS-CoV2 infection management.